Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Moderna Inc’s current trading price is -83.79% away from its 52-week high, while its distance from the 52-week low is -5.56%. The stock’s price range during this period has varied between $29.25 and $170.47. The company, active in the Healthcare sector, saw a trading volume of around 10.68 million for the day, considerably lower average daily volume of 11.34 million observed over the last three months.
Moderna Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $170.47 on 05/24/24, and the lowest price during the same period was recorded at $29.25 on 03/31/25.
How Financial Performance Impacts Market Capitalization
Moderna Inc (MRNA) has experienced a quarterly decline of -31.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.66B and boasts a workforce of 5800 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 38.26, with a change in price of -27.32. Similarly, Moderna Inc recorded 10,614,587 in trading volume during the last 100 days, posting a change of -50.01%.
How MRNA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MRNA stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.07.
MRNA Stock Stochastic Average
As of today, the raw stochastic average of Moderna Inc over the past 50 days is 2.73%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 4.49%. Additionally, the Stochastic %K and %D values for the company were 18.75% and 26.61%, respectively, over the past 20 days.
MRNA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -33.56%.However, over the last six months, we can see a stronger performance of -56.79%. Over the last 30 days, the price of MRNA has leaped by -10.77%. And in the last five days, it has fallen by -19.15%.
